COR - Cencora, Inc.
371.44
-1.210 -0.326%
Share volume: 1,190,357
Last Updated: 03-03-2026
Wholesale/Wholesale – Drugs & Drug Proprietaries:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$372.65
-1.21
0.00%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 02-05-2025 | 05-07-2025 | 08-06-2025 | 11-25-2025 | 02-04-2026 | |
| Total revenue | 81.487 B | 75.454 B | 80.664 B | 83.729 B | 85.932 B | |
| Cost of revenue | 78.929 B | 72.394 B | 77.756 B | 80.775 B | 82.860 B | |
| Gross profit | 2.558 B | 3.060 B | 2.907 B | 2.954 B | 3.072 B | |
| 19.62% | -4.99% | 1.60% | 4.01% | |||
| Operating expenses | 1.472 B | 1.600 B | 1.673 B | 1.749 B | 1.795 B | |
| Selling general and admin | 1.472 B | 1.600 B | 1.673 B | 1.749 B | 1.795 B | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 1.852 B | 2.024 B | 2.039 B | 2.935 B | 2.312 B | |
| 9.28% | 0.78% | 43.91% | -21.24% | |||
| Operating income | 706.254 M | 1.036 B | 867.654 M | 18.503 M | 760.449 M | |
| Ebit | 648.380 M | 1.033 B | 978.071 M | -109.211 M | 781.049 M | |
| Pretax income | 620.447 M | 928.656 M | 896.277 M | -187.044 M | 708.640 M | |
| 49.68% | -3.49% | -120.87% | -478.86% | |||
| Income tax | 126.728 M | 211.239 M | 206.528 M | 146.027 M | 142.514 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 493.719 M | 717.417 M | 689.749 M | -333.071 M | 566.126 M | |
| 45.31% | -3.86% | -148.29% | 269.97% |